109 related articles for article (PubMed ID: 16356838)
21. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
[TBL] [Abstract][Full Text] [Related]
22. Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.
Al-Kuraya KS; Bavi PP; Ezzat AA; Al-Dayel FA; Uddin S; Atizado VL; Al-Jomah NA; Amr SS; Sheikh SS; Sauter G; Simon R
Saudi Med J; 2006 Mar; 27(3):323-8. PubMed ID: 16532091
[TBL] [Abstract][Full Text] [Related]
23. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
24. [Molecular biology of colorectal cancer--Genetic abnormality: an aspect for an MSI pathway].
Hemmi H; Yamada K; Shimatake H; Koike J
Nihon Rinsho; 2003 Sep; 61 Suppl 7():81-5. PubMed ID: 14574860
[No Abstract] [Full Text] [Related]
25. Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer.
Jansson A; Arbman G; Zhang H; Sun XF
Int J Oncol; 2003 Jan; 22(1):41-9. PubMed ID: 12469183
[TBL] [Abstract][Full Text] [Related]
26. Implications of low COX-2 expression in colorectal neoplasms with defective DNA mismatch repair.
Karnes WE
J Cell Biochem Suppl; 2000; 34():23-7. PubMed ID: 10762011
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
[TBL] [Abstract][Full Text] [Related]
28. Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability.
Kim H; Piao Z; Kim JW; Choi JS; Kim NK; Lee JM; Park JH
Pathol Res Pract; 1998; 194(1):3-9. PubMed ID: 9542742
[TBL] [Abstract][Full Text] [Related]
29. Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis.
Jover R; Payá A; Alenda C; Poveda MJ; Peiró G; Aranda FI; Pérez-Mateo M
Am J Clin Pathol; 2004 Sep; 122(3):389-94. PubMed ID: 15362369
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.
Pedroni M; Sala E; Scarselli A; Borghi F; Menigatti M; Benatti P; Percesepe A; Rossi G; Foroni M; Losi L; Di Gregorio C; De Pol A; Nascimbeni R; Di Betta E; Salerni B; de Leon MP; Roncucci L
Cancer Res; 2001 Feb; 61(3):896-9. PubMed ID: 11221877
[TBL] [Abstract][Full Text] [Related]
31. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
Oh K; Redston M; Odze RD
Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188
[TBL] [Abstract][Full Text] [Related]
32. Mismatch repair deficiency leads to a unique mode of colorectal tumorigenesis characterized by intratumoral heterogeneity.
Habano W; Sugai T; Nakamura S
Oncogene; 1998 Mar; 16(10):1259-65. PubMed ID: 9546427
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.
Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY
Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
[TBL] [Abstract][Full Text] [Related]
35. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
36. Mismatch repair, p53 and chromosomal aberrations in primary colorectal carcinomas.
Mehigan BJ; Ashman JN; Baker RP; Macdonald A; Greenman J; Monson JR; Cawkwell L
Acta Oncol; 2006; 45(1):61-6. PubMed ID: 16464797
[TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
[TBL] [Abstract][Full Text] [Related]
39. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
Ortega P; Morán A; de Juan C; Frías C; Hernández S; López-Asenjo JA; Sánchez-Pernaute A; Torres A; Iniesta P; Benito M
Clin Cancer Res; 2008 Feb; 14(4):995-1001. PubMed ID: 18281531
[TBL] [Abstract][Full Text] [Related]
40. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
